This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 2 EPO patents. Top assignee: Immunogen, Inc.. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2022
Title: Innovations by Shengjin Jin: Pioneering Drug Conjugate Technologies
Introduction
Shengjin Jin is an accomplished inventor based in Acton, MA, known for his significant contributions to the field of drug conjugates. With a total of five patents to his name, Jin's work focuses on developing processes that enhance the efficacy of therapeutic agents through innovative chemical techniques.
Latest Patents
Jin's latest patents revolve around a "Process for preparing purified drug conjugates." This invention outlines a sophisticated method for creating a cell-binding agent that is chemically coupled to a drug. The patented process involves several critical steps: covalently attaching a linker to the cell-binding agent, performing a purification step, conjugating the drug to the cell-binding agent, and conducting a subsequent purification step. This innovative approach aims to improve the delivery and effectiveness of drug therapies.
Career Highlights
Currently employed at ImmunoGen, Inc., Shengjin Jin has made remarkable strides in the pharmaceutical industry. His work reflects a strong commitment to creating advanced drug delivery systems that have the potential to transform treatment options for various diseases.
Collaborations
Throughout his career, Jin has collaborated with esteemed colleagues, including Yong Dai and Yong Wang. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation that has been instrumental to their projects' success.
Conclusion
Shengjin Jin's inventive contributions, particularly in the realm of drug conjugate processes, underscore his role as a leading figure in pharmaceutical innovation. With ongoing efforts at ImmunoGen, Inc., Jin continues to push the boundaries of medical research, aiming to create more effective therapies for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
